These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27033080)

  • 21. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
    Wang S; Garcia AJ; Wu M; Lawson DA; Witte ON; Wu H
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1480-5. PubMed ID: 16432235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN mutation: many birds with one stone in tumorigenesis.
    Liu W; Zhou Y; Reske SN; Shen C
    Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibiting PTEN.
    Rosivatz E
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):257-9. PubMed ID: 17371253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN regulation of neural development and CNS stem cells.
    Li L; Liu F; Ross AH
    J Cell Biochem; 2003 Jan; 88(1):24-8. PubMed ID: 12461771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays to Measure PTEN Lipid Phosphatase Activity In Vitro from Purified Enzyme or Immunoprecipitates.
    Spinelli L; Leslie NR
    Methods Mol Biol; 2016; 1447():95-105. PubMed ID: 27514802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
    Zhang J; Grindley JC; Yin T; Jayasinghe S; He XC; Ross JT; Haug JS; Rupp D; Porter-Westpfahl KS; Wiedemann LM; Wu H; Li L
    Nature; 2006 May; 441(7092):518-22. PubMed ID: 16633340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of PTEN in the development of mouse cochlear lateral wall.
    Dong Y; Sui L; Yamaguchi F; Kamitori K; Hirata Y; Hossain A; Noguchi C; Katagi A; Nishio M; Suzuki A; Lou X; Tokuda M
    Neuroscience; 2014 Jan; 258():263-9. PubMed ID: 24252318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protein phosphatase activity of PTEN is essential for regulating neural stem cell differentiation.
    Lyu J; Yu X; He L; Cheng T; Zhou J; Cheng C; Chen Z; Cheng G; Qiu Z; Zhou W
    Mol Brain; 2015 Apr; 8():26. PubMed ID: 25927309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multiple layers of non-genetic regulation of PTEN tumour suppressor activity.
    Correia NC; Gírio A; Antunes I; Martins LR; Barata JT
    Eur J Cancer; 2014 Jan; 50(1):216-25. PubMed ID: 24054978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN inhibition enhances neurite outgrowth in human embryonic stem cell-derived neuronal progenitor cells.
    Wyatt LA; Filbin MT; Keirstead HS
    J Comp Neurol; 2014 Aug; 522(12):2741-55. PubMed ID: 24610700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATP modulates PTEN subcellular localization in multiple cancer cell lines.
    Lobo GP; Waite KA; Planchon SM; Romigh T; Houghton JA; Eng C
    Hum Mol Genet; 2008 Sep; 17(18):2877-85. PubMed ID: 18579579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.
    Langdon CG
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830628
    [No Abstract]   [Full Text] [Related]  

  • 37. PTEN at 18: Still Growing.
    Gorbenko O; Stambolic V
    Methods Mol Biol; 2016; 1388():13-9. PubMed ID: 27033067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pten is essential for embryonic development and tumour suppression.
    Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi PP
    Nat Genet; 1998 Aug; 19(4):348-55. PubMed ID: 9697695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
    Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN Tumor-Suppressor: The Dam of Stemness in Cancer.
    Luongo F; Colonna F; Calapà F; Vitale S; Fiori ME; De Maria R
    Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.